Exact Sciences Corp

EXAS:NASDAQ
RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 11:21 AM EST
147.68quote price arrow down-0.38 (-0.26%)
Volume
566,702
52 week range
35.25 - 152.87

...

Loading . . .

KEY STATS

  • Open146.84
  • Day High149.51
  • Day Low146.20
  • Prev Close148.07
  • 52 Week High152.87
  • 52 Week High Date01/20/21
  • 52 Week Low35.25
  • 52 Week Low Date03/18/20
  • Market Cap23,543.94M
  • Shares Out159.42M
  • 10 Day Average Volume2.08M
  • Dividend-
  • Dividend Yield-
  • Beta1.51
  • 1 Year % Change55.86

RATIOS/PROFITABILITY

  • EPS (TTM)-2.20
  • P/E (TTM)-67.24
  • Fwd P/E (NTM)-100.53
  • EBITDA (MRQ)-89.54M
  • ROE (MRQ)-21.64%
  • Revenue (MRQ)1,320.63M
  • Gross Margin (MRQ)75.49%
  • Net Margin (MRQ)-25.27%
  • Debt To Equity (MRQ)67.56%

EVENTS

  • Earnings Date02/09/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest EXAS News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Exact Sciences Corporation is a molecular diagnostics company. The Company focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer and Oncotype DX. Its Cologuard test is a stool-based deoxyribonucleic acid (sDNA) screening test, which utilizes a multi-target approach to detect deoxyribonucleic acid (DNA) and hemoglobin biomarkers associated with...
Kevin Conroy
Chairman
Jeffrey Elliott
Chief Financial Officer
Address
5505 ENDEAVOR LANE
Madison, WI
53719
United States